SEC Form 4 · accession 0001209191-16-154688
ACURA PHARMACEUTICALS, INC · ACUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James F Emigh
Officer — VP Corporate Development
Period of report
Dec 8, 2016
Accepted (ET)
Dec 12, 2016 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF3,F1,F2 | $0.915 | Dec 8, 2016 | A | 14,000 | A | — | Dec 7, 2026 | Common Stock | 14,000 | 14,000 | D |
Explanation of responses
- F1Exercise price is closing price of Issuer's common stock on December 8, 2016.
- F2one-twenty-fourth of shares underlying options vest and are exercisable on the last day of each month commencing December 31, 2016 and ending on November 30, 2018. Option vesting and exercisability is accelerated upon a qualifying change of control.
- F3Not Applicable.